Biologic properties of endothelial cells-progenitors and their reparative potential for cell therapy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

High incidence of atherosclerotic disorders of lower extremity blood vessels, their progressive course leading to incapacitation make further improvement both surgical and conservative and less invasive treatment modalities of patients with such pathology very important. Among conservative and less invasive methods the usage of stem endothelial cells-precursors is a promising therapy for management of those patients who cannot be treated surgically because of the character of vascular impairment or their somatic status.

Full Text

Restricted Access

About the authors

A. A. Keskinov

I.M. Sechenov Moscow Medical Academy

Author for correspondence.
Email: SBykovk@mail.ru
Russian Federation, Moscow

I. I. Eryemin

Institute of Rheumatology RAMS

Email: SBykovk@mail.ru
Russian Federation, Moscow

A. N. Shcherbyuk

I.M. Sechenov Moscow Medical Academy

Email: SBykovk@mail.ru
Russian Federation, Moscow

A. A. Ragimov

I.M. Sechenov Moscow Medical Academy

Email: SBykovk@mail.ru
Russian Federation, Moscow

E. L. Nasonov

Institute of Rheumatology RAMS

Email: SBykovk@mail.ru
Russian Federation, Moscow

S. N. Bykovskaya

Institute of Rheumatology RAMS

Email: SBykovk@mail.ru
Russian Federation, Moscow

References

  1. Lin Y., Weisdorf D.J., Solovey A. et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000; 105: 71—7.
  2. Hristov M., Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell Mol. Med. 2004; 8: 498-508.
  3. Davignon J., Ganz P. Role of endothelial dysfunction in Circulation. 2004; 109(23D Suppl 1: III 27-32.
  4. Dignat—George F., Sampol J. Circulation endothelial in vascular disordes: new insights into an old concept. Euv. J. Haematol. 2000; 65: 215-20.
  5. Folkman J., Shing Y. Control of angiogenesis by heparin and other sulfated polysacaharides. Adv. Exp. Med. Biol. 1992; 313: 355—64.
  6. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003; 9: 653-60.
  7. Asahara T., Murohara T., Sullivan A. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964—7.
  8. Peichev M., Naiyer A.J., Pereira D. et al. Expression of VEGFR—2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000; 95: 3106—12.
  9. Gehling U.M., Егдьп S., Schumacher U. et al. In vitro differentiation of endothelial cells from AC133—positive progenitor cells. Blood 2000; 95: 3106-12.
  10. Ouirici N.. Soligo D., Caneva L. et al. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br. J. Haematol. 2001; 115: 186-94.
  11. Sata М., Saiura A., Kunisato A. et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 2002; 8: 403—9.
  12. Lagaaij E.L., Cramer-Knijnenburg G.F., van Kemenade F.J. et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33-7.
  13. Szmitko P.E., Fedak P.W., Weisel R.D. et al. Endothelial progenitor cells: new hope for a broken heart. Circul. 2003; 107: 3093—100.
  14. Kawamoto A., Gwon H.C., Iwaguro H. et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circul. 2001; 103: 634-7.
  15. Kaushal S., Amiel G.E., Guleserian K.J. et al. Functional small- diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 2001; 9: 1035—40.
  16. Urbich C., Acher A., Heeschen C. et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 2005; 39: 733—42.
  17. Young P.P., Vaughan D.E., Hatzopoulos A.K. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog. Cardiovasc. Dis. 2007; 49: 421—9.
  18. Urbich C., DimmelerS. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004; 95: 343—53.
  19. Takahashi T., Kalka C., Masuda H. et al. Ischemia- and cytokine- induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999; 5: 434—8.
  20. Murohara T., Asahara T., Silver M. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 1998; 101: 2567-78.
  21. Suzuki T., Nishida M., Futami S. et al. Neoendothelialization after peripheral blood stem cell transplantation in humans: a case report of a Tokaimura nuclear accident victim. Cardiovasc. Res. 2003; 58: 487—92.
  22. Powell T.M., Paul J.D., Hill J.M. et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb. Vase. Biol. 2005; 25: 296—301.
  23. Wijelath E. S., Rahman S. , Murray J. et al. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J.Vasc. Surg. 2004; 39: 655-60.
  24. Schflchinger V., Assmus B., Britten M.B. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one—year results of the TOP CARE—AMI Trial. J. Am. Coll. Cardiol. 2004; 44: 1690-9.
  25. Liu J.W., Dunoyer—Geindre S., Serre—Beinier V. et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J. Thromb. Haemost. 2007; 5: 826—34.
  26. Nassiri S.M., Khaki Z., Soleimani M. et al. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J. Biomed. Sci. 2007; 14: 745-55.
  27. Rafii S., Avecilla S., Shmelkov S. et al. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann. NY Acad. Sci. 2003; 996: 49—60.
  28. Meyer G.P., Wollert K.C., Lotz J. et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST [Bone marrow transfer to enhance ST-elevation infarct regeneration] trial. Circul. 2006; 113: 1287—94.
  29. Koshikawa M., Shimodaira S., Yoshioka T. et al. Therapeutic angiogenesis by bone marrow implantation for critical hand ischemia in patients with peripheral arterial disease: a pilot study. Curr. Med. Res. Opin. 2006; 22: 793-8.
  30. ObradovbKS., RUSOVDKS., Balint B. et al. Autologous bone marrow- derived progenitor cell transplantation for myocardial regeneration after acute infarction. Vojnosanit. Pregl. 2004; 61: 519—29.
  31. Gulati R., Jevremovic D., Peterson T.E. et al. Autologous culture- modified mononuclear cells confer vascular protection after arterial injury. Circul. 2003; 108: 1520-6.
  32. Hur J., Yoon C.H. Kim H.S. et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vase. Biol. 2004; 24: 288—93.
  33. Yoon C.H., Hur J., Park K.W. et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circul. 2005; 112: 1618—27.
  34. Rehman J., Li J., Orschell C.M. et al. Peripheral blood «endothelial progenitor cells» are derived from monocyte/macrophages and secrete angiogenic growth factors. Circul. 2003; 107: 1164—9.
  35. Tateishi-Yuyama E., Matsubara H., Murohara T. et al.Therapeutic Angiogenesis using Cell Transplantation [TACT] Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427—35.
  36. Durdu S., Akar A.R., Arat M. et al. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II—III thromboangiitis obliterans. J. Vase. Surg. 2006; 44: 732—9.
  37. Kajiguchi M., Kondo T., Izawa H. et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ. J. 2007; 71: 196—201.
  38. Yang X.F., Wu Y.X., Wang H.M. et al. Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghua Nei Ke Za Zhi. 2005; 44: 95—8.
  39. Kawamura A., Horie T., Tsuda I. et al. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell CPBSC) transplantation in 92 patients with critically ischemic limbs. J. Artif. Organs 2006; 9: 226-33.
  40. Tateno K., Minamino T., Toko H. et al.Critical roles of muscle- secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 2006; 98: 1194-202.
  41. Huang P.P., Yang X.F., Li S.Z. et al. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow- mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb. Haemost. 2007; 98: 1335—42.
  42. Dong Y.Y., Wu M., Yim A.P. et al. Effect of hypoxia-reoxygenation on endothelial function in porcine cardiac microveins. Ann. Thorac. Surg. 2006; 81: 1708-14.
  43. Kudo F.A., Nishibe T., Nishibe M. et al. Autologous transplantation of peripheral blood endothelial progenitor cells CD34+ for therapeutic angiogenesis in patients with critical limb ischemia. Int. Angiol. 2003; 22: 344-8.
  44. Lenk K. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. European. Heart J. 2005; 26: 1903—9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies